commitment
The WHO announced last month that human trials will be conducted in the DRC to determine whether the Ervebo vaccine, approved for the Zaire Ebola strain, can also protect against Bundibugyo.
A commitment by ကမ္ဘာ့ကျန်းမာရေးအဖွဲ့ (WHO). Statements are as reported by the cited publishers — not verified by DecisionGateway.
ဒီအာကွန်ဂိုတွင် လူသားများဖြင့် စမ်းသပ်မှု ပြုလုပ်သွားမည်ဖြစ်ကြောင်း ကမ္ဘာ့ကျန်းမာရေးအဖွဲ့ (WHO) က ပြီးခဲ့သည့်လတွင် ကြေညာခဲ့သည်။
Discussion
Related claims
There are currently no approved vaccines or treatments for the Bundibugyo Ebola species, the main cause of the current outbreak.post author · statementConfirmed Ebola patients in the DRC's worst outbreak in history have reached over 11,000, according to official government figures released on November 11.အစိုးရ၏ နိုဝင်ဘာ ၁၁ ရက် ထုတ်ပြန်သည့် တရားဝင်ကိန်းဂဏန်းများ · statementEbola cases in DR Congo exceed 11,000.authorities · statementAccording to the DRC National Public Health Institute, 11,042 people have been infected and 5,387 have died.ဒီအာကွန်ဂို အမျိုးသား ပြည်သူ့ကျန်းမာရေး ဌာန · statementHealth authorities said youths burned down a health center treating Ebola patients in the Lolwa area of Ituri province on November 8.ကျန်းမာရေး အာဏာပိုင်များ · allegationThe current outbreak started in Ituri province in the northeast and spread to seven other provinces, with most cases in Ituri and North Kivu.post author · statement